Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to see a gradual recovery in performance throughout 2025, with a focus on high dividend returns to shareholders [8] - The jewelry industry is currently facing significant sales pressure due to rising gold prices, which has impacted the company's performance [8] - The company has reported a significant increase in gross margin, attributed to rising gold prices and improved product mix [8] Financial Performance Summary - Total revenue for 2023 is projected at 16,290 million, with a decline to 13,891 million in 2024, followed by a recovery to 15,225 million in 2025 [1] - Net profit attributable to shareholders is expected to decrease from 1,316 million in 2023 to 1,010 million in 2024, with a slight recovery to 1,112 million in 2025 [1] - The latest diluted EPS is forecasted to be 0.92 in 2024, increasing to 1.01 in 2025 [1] Revenue and Profitability Metrics - The gross margin for 2024 is expected to be 20.80%, improving to 26.21% in Q1 2025 [8] - The net profit margin for 2024 is projected at 7.27%, with an increase to 9.43% in Q1 2025 [8] - The company aims for a cumulative cash distribution of at least 50% of its distributable profits over any three consecutive years [8] Channel Performance - Self-operated and e-commerce channels have shown relatively better performance, while the number of terminal stores has decreased [8] - In Q1 2025, self-operated offline revenue was 5.27 billion, e-commerce revenue was 5.34 billion, and franchise revenue was 5.84 billion, reflecting varying performance across product categories [8] Future Outlook - The company anticipates a sequential improvement in performance starting from Q2 2025, supported by a low base effect [8] - The forecast for net profit for 2025 has been adjusted to 11.1 billion, with a new projection for 2027 at 13.1 billion [8]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to see a gradual recovery in performance throughout 2025, following a challenging 2024 due to pressures in the gold jewelry industry [8] - The company has a strong dividend policy, committing to distribute at least 50% of its cumulative distributable profits in cash over any three consecutive years [8] - Despite a decline in revenue and net profit in 2024, the company anticipates a return to growth in 2025, with quarterly improvements expected starting from Q2 2025 [8] Financial Performance Summary - Total revenue for 2024 is projected at 13.89 billion yuan, a decrease of 14.73% year-on-year, with a net profit of 1.01 billion yuan, down 23.25% [8] - For Q1 2025, revenue is expected to be 2.673 billion yuan, reflecting a 47.3% decline year-on-year, with a net profit of 252 million yuan, down 26.1% [8] - The gross margin improved significantly, with 2024 gross margin at 20.80% (up 2.6 percentage points) and Q1 2025 gross margin at 26.21% (up 10.6 percentage points) [8] - The company’s net profit margin for 2024 is 7.27%, slightly down from the previous year, while Q1 2025 shows an increase to 9.43% [8] Revenue and Profit Forecast - Revenue is expected to grow to 15.23 billion yuan in 2025, with a year-on-year increase of 9.60%, and net profit is projected to reach 1.11 billion yuan, up 10.07% [1][8] - The company’s earnings per share (EPS) is forecasted to be 1.01 yuan in 2025, with a price-to-earnings (P/E) ratio of 12.84 based on the latest diluted EPS [1][8] Market Data - The closing price of the stock is 13.03 yuan, with a market capitalization of approximately 14.28 billion yuan [5] - The company has a price-to-book (P/B) ratio of 2.16 and a net asset value per share of 6.03 yuan [5][6]

一家公司的股东回报政策往往是衡量其价值的第一道标尺，迈瑞医疗这份刚刚发布的2024年报，再次刷 新了市场对"高分红"的认知，同时公司也表达出用AI加速转型的决心。 2025年4月28日晚间，迈瑞医疗公布2024年年报及2025年一季报，公司在2024年营收净利同比正增长，但 在宏观环境出现巨大变化之下，25Q1出现同比出现负增长。然而相较于24Q4，Q1公司业绩环比已大幅改 善，经营质量持续提升。 截至一季报期末，公司现金余额超过159亿元；公司2024年全年累计派发现金红利总额达到76.02亿元，分 红比例为65.15% ；此外公司拟以25Q1末股本基数，实施25年第一次中期分红，金额17.10亿元。公司在行 业面临更多挑战的当下，延续了高分红传统，并计划在2025年新增中期分红，进一步提升资金回馈的灵 活性与频率。 值得关注的是，在延续高分红传统的同时，迈瑞正加速推进AI战略布局。2024年12月，公司发布全球首 个临床落地的重症医疗大模型——"启元"，标志着从传统设备供应商向智能医疗解决方案提供商的战略 转型迈出关键一步。 这种在保持高分红传统的同时积极拥抱技术创新的模式，正在重塑医疗器械企业的价值体系 ...

Core Viewpoint - Aimer Co., Ltd. reported a significant decline in both revenue and net profit for the fiscal year 2024, indicating severe challenges due to weak consumer demand and intensified industry competition [3][4]. Financial Performance - In 2024, Aimer's total revenue was 3.163 billion yuan, a year-on-year decrease of 7.71% - The net profit attributable to shareholders was 163 million yuan, down 46.56% year-on-year, falling short of market expectations [3][4]. - For Q1 2025, Aimer's revenue was 854 million yuan, a decline of 2.86% year-on-year, with net profit at 85.56 million yuan, down 20.26% year-on-year [5]. Business Structure - Revenue from core product lines saw varying degrees of decline, with lingerie revenue down 15.83% and homewear, thermal clothing, and underwear experiencing declines between 4% and 9% [3]. - The decline in revenue was attributed mainly to reduced foot traffic, with offline direct sales down 7.96% and online sales down 8.14% [4]. Dividend Policy - Despite poor overall performance, Aimer announced a substantial cash dividend of 4 yuan per 10 shares, totaling 99.55% of net profit, raising concerns about future funding reserves [4]. Cost Management - Aimer's sales expenses decreased by 4.42% due to reduced promotional spending, while management expenses increased by 6.33% due to higher personnel costs [4]. - The inventory level remained high at 982 million yuan, with a provision for inventory impairment at 21.85%, indicating significant inventory digestion pressure [4]. Strategic Adjustments - In response to performance challenges, Aimer is focusing on the sportswear segment by establishing dedicated divisions for the "Aimer Sports" and "Chichu" brands and accelerating channel restructuring [4]. - Although R&D investment decreased by 3.01%, Aimer added 58 new patents, including 26 Chinese invention patents [4].

Group 1 - As of April 30, 2024, 5,402 A-share listed companies have disclosed their annual reports, with total revenue of 71.92 trillion yuan, a year-on-year decrease of 0.23%, and a net profit attributable to shareholders of 5.21 trillion yuan, down 2.98% year-on-year [1] - Among the companies that disclosed their annual reports, 4,029 achieved profitability, accounting for 75% [1] - The top ten companies in terms of planned dividend amounts include Industrial and Commercial Bank of China, China Mobile, China Construction Bank, and China Merchants Bank, with Kweichow Moutai leading the per-share dividend at 276.24 yuan (including tax) [2] Group 2 - Over 500 companies have a per-share dividend exceeding 0.5 yuan (including tax), and about 160 companies have a per-share dividend exceeding 1 yuan (including tax) [2] - Industries such as agriculture, forestry, animal husbandry, fishery, non-bank financials, electronics, transportation, and automotive have shown significant performance recovery in their annual reports [2] - The recovery in these industries is closely related to the rebound in market demand and optimization of industry structure [2] Group 3 - A total of 3,645 out of 5,317 companies that announced profit distribution plans intend to carry out cash dividends, accounting for 68.55% [4] - Many companies have introduced share transfer plans alongside their dividend proposals, with 335 companies planning to conduct share transfers, and companies like New Aluminum Era and Huihan Shares leading in transfer ratios [2] - High dividend payouts combined with profit growth signal positive market sentiment and enhance investor confidence [3]

Investment Rating - The report maintains a "Buy" rating for the company [1]. Core Views - The company has shown stable performance over 2024, but faced pressure in Q1 2025, with a significant decline in revenue and net profit. The company remains a leader in the home textile industry, and its high dividend payout provides stable returns for investors [1][10]. - In 2024, the company achieved a revenue of 3.01 billion yuan, a year-on-year decrease of 0.6%, and a net profit of 540 million yuan, down 5.2% year-on-year. The first quarter of 2025 saw a more pronounced decline, with revenue dropping 17.8% and net profit falling 54.1% [5][6]. Summary by Sections Financial Performance - In 2024, the company’s revenue and net profit showed a slight decline, with revenue at 3.01 billion yuan and net profit at 540 million yuan. The first quarter of 2025 reported revenue of 540 million yuan and net profit of 56.14 million yuan, reflecting a significant year-on-year decline [5][6]. - The company’s gross margin improved to 56.1% in 2024, with a slight increase in various product categories [8][15]. Revenue Breakdown - In 2024, the revenue from different product categories was as follows: bedding sets (39.7%), comforters (39.8%), and pillows (7.2%), with respective year-on-year changes of -0.2%, -1.6%, and -2.8% [7]. - Revenue from various sales channels in 2024 showed a decline in e-commerce sales by 7.4%, while franchise and direct sales saw slight increases of 1.4% and 1.8%, respectively [7]. Dividend and Shareholder Returns - The company proposed a cash dividend of 0.62 yuan per share for 2024, resulting in a dividend payout ratio of 96%. The current dividend yield is 7.9% based on the stock price as of April 29, 2025 [5][10]. Future Earnings Forecast - The report projects net profits for 2025, 2026, and 2027 to be 548 million yuan, 574 million yuan, and 596 million yuan, respectively, with corresponding EPS of 0.65 yuan, 0.68 yuan, and 0.71 yuan [10][11].

Core Viewpoint - The company reported a slight increase in revenue for 2024 but a significant decline in net profit, indicating potential challenges ahead in profitability despite stable revenue growth in certain segments [1][2]. Financial Performance - In 2024, the company achieved a revenue of 27.539 billion yuan, a year-on-year increase of 2.78%, while the net profit attributable to shareholders was 2.169 billion yuan, a year-on-year decrease of 32.79% [1]. - The fourth quarter of 2024 saw a revenue of 6.654 billion yuan, a year-on-year increase of 2.20%, but a net loss of 395 million yuan, reflecting a significant decline in profitability [1]. - For Q1 2025, revenue was 7.060 billion yuan, a year-on-year decrease of 3.21%, while net profit was 686 million yuan, down 27.86% year-on-year [1]. Product Performance - The company has a titanium dioxide production capacity of 1.51 million tons per year, with 2024 production and sales volumes of 1.2955 million tons and 1.2545 million tons, respectively, showing increases of 8.74% and 8.25% year-on-year [2]. - Titanium concentrate production for 2024 was approximately 1.493 million tons, a year-on-year increase of 1.25%, with prices remaining relatively high, indicating stable profitability [2]. - Iron ore sales faced pressure with a total of 3.0022 million tons sold in 2024, a decrease of 30.80%, while sponge titanium sales increased by 42.57% [2]. Shareholder Returns - The company maintained a high dividend payout, distributing 2.144 billion yuan in 2024 and 1.186 billion yuan in Q1 2025, resulting in a dividend yield of approximately 5.48% based on a market capitalization of 39.1 billion yuan [3]. One-time Expenses - The company incurred significant one-time expenses in Q4 2024, including interest expenses related to the planned spin-off of a subsidiary and goodwill impairment, totaling approximately 554 million yuan [4][5]. - The company repurchased shares from strategic investors for a total of 2.597 billion yuan, including interest payments of about 325 million yuan [4]. Future Outlook - The company is expected to achieve revenues of 28.927 billion yuan, 30.251 billion yuan, and 31.505 billion yuan from 2025 to 2027, with net profits projected at 2.876 billion yuan, 3.845 billion yuan, and 4.081 billion yuan, respectively [6].

Core Viewpoint - The company's performance has declined due to falling self-produced coal prices, but it shows potential for high dividends and growth, maintaining a "buy" rating [1] Group 1: Financial Performance - In Q1 2025, the company achieved operating revenue of 38.39 billion yuan, a year-on-year decrease of 15.4% and a quarter-on-quarter decrease of 21.6% [1] - The net profit attributable to shareholders was 3.98 billion yuan, down 20% year-on-year and 15.5% quarter-on-quarter [1] - The non-recurring net profit attributable to shareholders was 3.94 billion yuan, a year-on-year decrease of 19.4% and a quarter-on-quarter decrease of 15.7% [1] - The company maintains profit forecasts for 2025-2027, expecting net profits of 17.05 billion, 18.47 billion, and 19.07 billion yuan, with year-on-year changes of -11.8%, +8.3%, and +3.3% respectively [1] Group 2: Coal Business Performance - In Q1 2025, the company produced and sold 33.35 million and 64.14 million tons of commodity coal, representing year-on-year increases of 1.9% and 0.4%, but quarter-on-quarter decreases of 5.4% and 19.1% [2] - The average selling price of coal in Q1 2025 was 487.2 yuan per ton, down 17% year-on-year and 9.8% quarter-on-quarter [2] - The comprehensive cost of coal was 371 yuan per ton, a year-on-year decrease of 13.4% and a quarter-on-quarter decrease of 9.4% [2] - The gross profit per ton of coal was 116.2 yuan, down 26.7% year-on-year and 11.2% quarter-on-quarter [2] Group 3: Coal Chemical Business Performance - In Q1 2025, the production of polyolefins, urea, methanol, and ammonium nitrate was 37.8, 52.8, 51.4, and 13.9 million tons, with year-on-year changes of -3.6%, +11.2%, +24.8%, and +6.9% respectively [2] - The selling prices for polyolefins, urea, methanol, and ammonium nitrate were 6,876, 1,702, 1,794, and 1,861 yuan per ton, with year-on-year changes of +0.4%, -23.9%, +7.1%, and -17.3% respectively [2] - The gross profit per ton for polyolefins, urea, methanol, and ammonium nitrate was 1,101, 360, 380, and 386 yuan per ton, with year-on-year changes of +16%, -46.7%, +675.8%, and -47.6% respectively [2] Group 4: Growth Potential and Dividend Policy - The company has two coal mines under construction, with expected production capacities of 4 million tons/year and 2.4 million tons/year, respectively, set to begin trial production by the end of 2025 [3] - The company plans to invest 23.888 billion yuan in a coal deep processing project, with a construction scale of 900,000 tons/year of polyolefins, and has already completed significant investment [3] - The cash dividend amount for 2024 is expected to be 6.35 billion yuan, with a dividend payout ratio of 32.87%, indicating potential for increased dividends in the future [3]

Core Viewpoint - The company reported its 1Q25 performance, showing a decline in revenue and net profit due to a drop in OTC sales, but a significant improvement in gross margin. The company is viewed positively as a leader in the domestic OTC market, with stable growth prospects and a strong dividend foundation, maintaining a "Buy" rating [1]. Group 1: Financial Performance - 1Q25 revenue, net profit attributable to shareholders, and net profit excluding non-recurring items were 1.18 billion, 280 million, and 260 million respectively, reflecting a year-over-year change of -7.0%, +5.9%, and -1.1% [1]. - OTC segment revenue in 1Q25 was 890 million, down 12.1% year-over-year, with a gross margin of 76.1%, up 2.1 percentage points year-over-year [2]. - Prescription drug revenue in 1Q25 was 190 million, up 23.7% year-over-year, with a gross margin of 23.7%, up 9.2 percentage points year-over-year [2]. - Health consumer products revenue in 1Q25 was 110 million, up 0.6% year-over-year, with a gross margin of 37.0%, down 3.6 percentage points year-over-year [2]. - The company's gross margin improved to 68.2% in 1Q25, up 13.1 percentage points quarter-over-quarter, mainly due to adjustments in the beverage business [3]. Group 2: Cost Management and Efficiency - The company's selling, general, and administrative expense ratios were 33.8%, 4.5%, and 2.3% respectively, showing an overall decrease in expense ratios [3]. - As of 1Q25, accounts receivable, inventory, and cash were 640 million, 430 million, and 1.62 billion respectively, indicating good inventory and cash turnover [3]. Group 3: Shareholder Returns and Incentives - The company's stock incentive plan was approved in 4M25, with enhanced unlocking conditions for 2025-27, reflecting confidence in operational goals [4]. - In 2024, the company's cash dividends accounted for 95.77% of the net profit attributable to shareholders, highlighting a strong commitment to shareholder returns [4]. - The company emphasized its focus on investor returns in its 2025 action plan, aiming to share the benefits of its growth with shareholders [4]. Group 4: Future Outlook - The company maintains its profit forecast, expecting net profits attributable to shareholders for 2025-27 to be 897 million, 1.015 billion, and 1.145 billion respectively, reflecting year-over-year growth of 14%, 13%, and 13% [5]. - The company is assigned a target price of 29.96, based on a 21x PE ratio for 2025, maintaining a "Buy" rating [5].

事件：2025 年4 月25 日，公司发布了2024 年度报告及2025 年一季报。2024年，公司营业收入1841.5 亿 元，同比+1.5%，归母净利润223.6 亿元，同比-3.2%，扣非净利润211.6 亿元，同比-14.3%；2025Q1 公 司营业收入401.6 亿元（同比-7.3%、环比-17.5%），归母净利润48.1 亿元（同比-1.2%、环比-1.8%）， 扣非净利润45.5 亿元（同比-2.0%、环比-5.4%）（同环比数据均为调整后口径）。 高分红回馈股东，股息率高达6.7%。公司2024 年度利润分配预案为，每股派发人民币1.136 元（含 税），叠加中期、三季度已分别派发现金股利每股0.109元（含税）、每股0.103 元（含税），公司2024 年合计每股分红1.348 元（含税），全年分红比例高达58.45%，现金分红总金额占可供分配利润比例达 65%，对应A 股年度股息率为6.74%（按2025 年4 月25 日收盘价计算）。 盈利预测、估值与评级：考虑到2025 年煤炭市场价格较2024 年将有所下滑，我们下调25-26 年归母净 利润预测3.7%、1.4%至202、212 ...